Abstract
Chromatin structure is determined by nucleosome positioning, histone modifications, and DNA methylation. How chromatin modifications are coordinately altered under pathological conditions remains elusive. Here we describe a stress-activated mechanism of concerted chromatin modification in the heart. In mice, pathological stress activates cardiomyocytes to express Brg1 (nucleosome-remodeling factor), G9a/Glp (histone methyltransferase), and Dnmt3 (DNA methyltransferase). Once activated, Brg1 recruits G9a and then Dnmt3 to sequentially assemble repressive chromatin-marked by H3K9 and CpG methylation-on a key molecular motor gene (Myh6), thereby silencing Myh6 and impairing cardiac contraction. Disruption of Brg1, G9a or Dnmt3 erases repressive chromatin marks and de-represses Myh6, reducing stress-induced cardiac dysfunction. In human hypertrophic hearts, BRG1-G9a/GLP-DNMT3 complex is also activated; its level correlates with H3K9/CpG methylation, Myh6 repression, and cardiomyopathy. Our studies demonstrate a new mechanism of chromatin assembly in stressed hearts and novel therapeutic targets for restoring Myh6 and ventricular function. The stress-induced Brg1-G9a-Dnmt3 interactions and sequence of repressive chromatin assembly on Myh6 illustrates a molecular mechanism by which the heart epigenetically responds to environmental signals. This article is part of a Special Issue entitled: Cardiomyocyte Biology: Integration of Developmental and Environmental Cues in the Heart edited by Marcus Schaub and Hughes Abriel.
Keywords:
Brg1; Cardiac hypertrophy; Cardiomyopathy; Chromatin remodeling; DNA methylation; Dnmt; G9a; Gene silencing; H3K9me2; Heart failure; Histone methylation; Myosin heavy chain.
Copyright © 2016. Published by Elsevier B.V.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adaptation, Physiological
-
Animals
-
Cardiomegaly / enzymology*
-
Cardiomegaly / genetics
-
Cardiomegaly / pathology
-
Cardiomegaly / physiopathology
-
Cardiomyopathies / enzymology*
-
Cardiomyopathies / genetics
-
Cardiomyopathies / pathology
-
Cardiomyopathies / physiopathology
-
Chromatin / genetics
-
Chromatin / metabolism*
-
Chromatin Assembly and Disassembly*
-
CpG Islands
-
DNA (Cytosine-5-)-Methyltransferases / deficiency
-
DNA (Cytosine-5-)-Methyltransferases / genetics
-
DNA (Cytosine-5-)-Methyltransferases / metabolism*
-
DNA Helicases / deficiency
-
DNA Helicases / genetics
-
DNA Helicases / metabolism*
-
DNA Methylation
-
DNA Methyltransferase 3A
-
Disease Models, Animal
-
Epigenesis, Genetic*
-
Gestational Age
-
Histone-Lysine N-Methyltransferase / deficiency
-
Histone-Lysine N-Methyltransferase / genetics
-
Histone-Lysine N-Methyltransferase / metabolism*
-
Histones / metabolism
-
Humans
-
Methylation
-
Mice, Knockout
-
Myocardium / enzymology*
-
Myocardium / pathology
-
Myosin Heavy Chains / genetics
-
Myosin Heavy Chains / metabolism*
-
Nuclear Proteins / deficiency
-
Nuclear Proteins / genetics
-
Nuclear Proteins / metabolism*
-
Promoter Regions, Genetic*
-
Protein Binding
-
Protein Processing, Post-Translational
-
Recovery of Function
-
Signal Transduction
-
Stress, Physiological*
-
Transcription Factors / deficiency
-
Transcription Factors / genetics
-
Transcription Factors / metabolism*
-
Ventricular Function, Left
Substances
-
Chromatin
-
DNMT3A protein, human
-
Histones
-
Myh6 protein, mouse
-
Nuclear Proteins
-
Transcription Factors
-
DNA (Cytosine-5-)-Methyltransferases
-
DNA Methyltransferase 3A
-
G9a protein, mouse
-
GLP protein, mouse
-
Histone-Lysine N-Methyltransferase
-
Smarca4 protein, mouse
-
DNA Helicases
-
Myosin Heavy Chains